Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group

BACKGROUND: This study evaluated the safety and efficacy of nab-paclitaxel as second-line treatment in patients with advanced gastric adenocarcinoma. METHODS: Thirty-nine pretreated patients [33 with taxane-based regimens (docetaxel, cisplatin, and fluorouracil)] and 6 with combination of fluoropyri...

Full description

Saved in:
Bibliographic Details
Published in:Ann Gastroenterol
Main Authors: Katsaounis, Panagiotis, Kotsakis, Athanasios, Kentepozidis, Nikolaos, Polyzos, Aris, Bakogeorgos, Marios, Koinis, Filippos, Vamvakas, Lambros, Vardakis, Nikolaos, Kalbakis, Kostas, Boukovinas, Ioannis, Varthalitis, Ioannis I., Prinarakis, Efthimios, Georgoulias, Vassilis, Souglakos, John
Format: Artigo
Language:Inglês
Published: Hellenic Society of Gastroenterology 2018
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5759614/
https://ncbi.nlm.nih.gov/pubmed/29333068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2017.0215
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items